NDAINJECTIONINJECTABLEPriority Review
Approved
Oct 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15
Mechanism of Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Class:
Nucleoside Metabolic Inhibitor
Clinical Trials (5)
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
Started Sep 2011
47 enrolled
Chronic Lymphocytic Leukemia
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Started May 2011
10 enrolled
Chronic Lymphocytic LeukemiaB-Cell Non-Hodgkin's Lymphoma
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Started Jul 2006
14 enrolled
Hematologic Malignancies
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
Started Jun 2005
100 enrolled
Lymphoma
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Started May 2005
49 enrolled
LeukemiaLymphoma